Synageva BioPharma
Waltham
About Synageva BioPharma
Synageva is a biopharmaceutical company dedicated to developing and commercializing novel, next generation and follow on protein therapeutics that leverage the unique competitive advantages of their proprietary Synageva Expression Platform (SEPTM).
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 251 – 500
- Total funding: $597.4M
- Funding stage: M&A
- Last round: Post-IPO Equity (Jan 2015)
- Ticker: nasdaq:GEVA
- Website: synageva.com
- Phone: (781)357-9900
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/synageva-biopharma-3301416 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.